Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-28

Clinical Trial Results: Uric Acid Lowering Trial in Youth Onset T2D [Phase 2]

View source ↗

Summary

Phase 2 trial results for an uric acid-lowering therapy in youth-onset type 2 diabetes; study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetic Kidney Disease, Hyperuricemia | Phase 2 | Status: COMPLETED | Results posted: 2026-07-28